HEADER ANTIBIOTIC 13-AUG-21 7V4O TITLE UNIQUE NON-HEME HYDROXYLASE IN BIOSYNTHESIS OF NUCLEOSIDE ANTIBIOTIC TITLE 2 PATHWAY UNCOVER MECHANISM OF REACTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-HYDROXYLASE; COMPND 3 CHAIN: B, A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOMYCES SP. MK730-62F2; SOURCE 3 ORGANISM_TAXID: 643403; SOURCE 4 GENE: CPZ10; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI-PICHIA PASTORIS SHUTTLE VECTOR SOURCE 6 PPPGUT1; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 1182037 KEYWDS CAPRAZAMYCIN, MRAY, BETA-HYDROXYLASE, ANTIBIOTIC EXPDTA X-RAY DIFFRACTION AUTHOR T.L.LI,M.Z.SAEID REVDAT 3 29-NOV-23 7V4O 1 REMARK REVDAT 2 10-AUG-22 7V4O 1 JRNL REVDAT 1 23-FEB-22 7V4O 0 JRNL AUTH S.M.ZADEH,M.H.CHEN,Z.C.WANG,E.K.ASTANI,I.W.LO,K.H.LIN, JRNL AUTH 2 N.S.HSU,K.ADHIKARI,S.Y.LYU,H.Y.TSAI,Y.TERASAWA,M.YABE, JRNL AUTH 3 K.YAMAMOTO,S.ICHIKAWA,T.L.LI JRNL TITL BETA-HYDROXYLATION OF JRNL TITL 2 ALPHA-AMINO-BETA-HYDROXYLBUTANOYL-GLYCYLURIDINE CATALYZED BY JRNL TITL 3 A NONHEME HYDROXYLASE ENSURES THE MATURATION OF CAPRAZAMYCIN JRNL REF COMMUN CHEM V. 5 87 2022 JRNL REFN ESSN 2399-3669 JRNL DOI 10.1038/S42004-022-00703-6 REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.18.2_3874: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.03 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 46715 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.280 REMARK 3 FREE R VALUE TEST SET COUNT : 1999 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 3.9700 - 3.1500 0.98 3240 139 0.1638 0.1866 REMARK 3 2 3.1500 - 2.7500 1.00 3244 145 0.1830 0.1989 REMARK 3 3 2.7500 - 2.5000 1.00 3262 144 0.1877 0.2336 REMARK 3 4 2.5000 - 2.3200 1.00 3215 147 0.1867 0.2472 REMARK 3 5 2.3200 - 2.1900 1.00 3244 143 0.1864 0.2162 REMARK 3 6 2.1900 - 2.0800 0.99 3196 145 0.1856 0.2235 REMARK 3 7 2.0800 - 1.9900 0.99 3198 141 0.1933 0.2309 REMARK 3 8 1.9900 - 1.9100 1.00 3210 144 0.1893 0.2092 REMARK 3 9 1.9100 - 1.8400 0.99 3200 146 0.1864 0.2171 REMARK 3 10 1.8400 - 1.7900 1.00 3214 144 0.1904 0.2145 REMARK 3 11 1.7900 - 1.7400 1.00 3216 142 0.1936 0.2309 REMARK 3 12 1.7400 - 1.6900 1.00 3167 149 0.1966 0.2432 REMARK 3 13 1.6900 - 1.6500 0.94 3060 130 0.1989 0.2271 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.150 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.360 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 3002 REMARK 3 ANGLE : 1.030 4064 REMARK 3 CHIRALITY : 0.063 438 REMARK 3 PLANARITY : 0.006 530 REMARK 3 DIHEDRAL : 22.852 430 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7V4O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 20-AUG-21. REMARK 100 THE DEPOSITION ID IS D_1300023988. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-JUL-20 REMARK 200 TEMPERATURE (KELVIN) : 80 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSRRC REMARK 200 BEAMLINE : TPS 05A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46721 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.650 REMARK 200 RESOLUTION RANGE LOW (A) : 25.030 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 32.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.71 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 4P7X REMARK 200 REMARK 200 REMARK: THE ENTRY CONTAINS FRIEDEL PAIRS IN I_PLUS/MINUS COLUMNS. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M LITHIUM SULFATE MONOHYDRATE 0.1M REMARK 280 ADA PH 6.5 12% PEG 4K 2% V/V 2-PROPANOL, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 75.41950 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.51750 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 75.41950 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 19.51750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3080 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16320 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET B 1 REMARK 465 PRO B 2 REMARK 465 GLY B 179 REMARK 465 GLU B 180 REMARK 465 SER B 181 REMARK 465 LYS B 182 REMARK 465 MET A 1 REMARK 465 PRO A 2 REMARK 465 GLY A 179 REMARK 465 GLU A 180 REMARK 465 SER A 181 REMARK 465 LYS A 182 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS B 141 O HOH B 301 2.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE B 41 172.46 75.59 REMARK 500 PHE A 41 170.31 81.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 526 DISTANCE = 5.88 ANGSTROMS REMARK 525 HOH B 527 DISTANCE = 6.00 ANGSTROMS REMARK 525 HOH B 528 DISTANCE = 6.30 ANGSTROMS REMARK 525 HOH A 492 DISTANCE = 6.17 ANGSTROMS REMARK 525 HOH A 493 DISTANCE = 6.37 ANGSTROMS DBREF 7V4O B 1 182 UNP C4NCJ7 C4NCJ7_9ACTN 1 182 DBREF 7V4O A 1 182 UNP C4NCJ7 C4NCJ7_9ACTN 1 182 SEQADV 7V4O ALA B 170 UNP C4NCJ7 ARG 170 ENGINEERED MUTATION SEQADV 7V4O ALA A 170 UNP C4NCJ7 ARG 170 ENGINEERED MUTATION SEQRES 1 B 182 MET PRO GLY ARG ARG LYS ALA CYS PHE VAL THR ALA LEU SEQRES 2 B 182 THR SER ARG THR GLU LEU ASP ILE ASP PRO ASP LYS LEU SEQRES 3 B 182 ARG GLU SER VAL VAL GLU LEU LEU GLU ARG HIS PRO LEU SEQRES 4 B 182 VAL PHE GLU GLY THR ARG GLN LEU ALA LEU GLN HIS ARG SEQRES 5 B 182 PRO GLU ALA THR ASP PRO TRP TYR GLU GLY CYS GLN ARG SEQRES 6 B 182 GLN SER LEU ILE SER SER ASP SER ASP PHE THR GLU VAL SEQRES 7 B 182 HIS GLY GLU LEU ARG ASP THR TYR LEU GLY GLU VAL PHE SEQRES 8 B 182 ASP ARG LEU PRO PHE LYS PRO ILE ARG THR ARG ILE MET SEQRES 9 B 182 ALA LEU ASP PRO LYS TYR CYS TYR SER VAL HIS ARG ASP SEQRES 10 B 182 LEU THR PRO ARG TYR HIS LEU ALA VAL THR THR SER GLU SEQRES 11 B 182 HIS ALA ARG PHE VAL PHE ILE GLU HIS ASP LYS VAL LEU SEQRES 12 B 182 HIS ILE PRO ALA ASP GLY ASP LEU TYR TYR VAL ASP THR SEQRES 13 B 182 ARG GLN LEU HIS SER ALA PHE ASN GLY GLY ASP ASP MET SEQRES 14 B 182 ALA ILE HIS ILE VAL PHE GLY THR ASP GLY GLU SER LYS SEQRES 1 A 182 MET PRO GLY ARG ARG LYS ALA CYS PHE VAL THR ALA LEU SEQRES 2 A 182 THR SER ARG THR GLU LEU ASP ILE ASP PRO ASP LYS LEU SEQRES 3 A 182 ARG GLU SER VAL VAL GLU LEU LEU GLU ARG HIS PRO LEU SEQRES 4 A 182 VAL PHE GLU GLY THR ARG GLN LEU ALA LEU GLN HIS ARG SEQRES 5 A 182 PRO GLU ALA THR ASP PRO TRP TYR GLU GLY CYS GLN ARG SEQRES 6 A 182 GLN SER LEU ILE SER SER ASP SER ASP PHE THR GLU VAL SEQRES 7 A 182 HIS GLY GLU LEU ARG ASP THR TYR LEU GLY GLU VAL PHE SEQRES 8 A 182 ASP ARG LEU PRO PHE LYS PRO ILE ARG THR ARG ILE MET SEQRES 9 A 182 ALA LEU ASP PRO LYS TYR CYS TYR SER VAL HIS ARG ASP SEQRES 10 A 182 LEU THR PRO ARG TYR HIS LEU ALA VAL THR THR SER GLU SEQRES 11 A 182 HIS ALA ARG PHE VAL PHE ILE GLU HIS ASP LYS VAL LEU SEQRES 12 A 182 HIS ILE PRO ALA ASP GLY ASP LEU TYR TYR VAL ASP THR SEQRES 13 A 182 ARG GLN LEU HIS SER ALA PHE ASN GLY GLY ASP ASP MET SEQRES 14 A 182 ALA ILE HIS ILE VAL PHE GLY THR ASP GLY GLU SER LYS HET P3G B 201 17 HET P3G A 201 17 HETNAM P3G 3,6,9,12,15-PENTAOXAHEPTADECANE FORMUL 3 P3G 2(C12 H26 O5) FORMUL 5 HOH *421(H2 O) HELIX 1 AA1 PHE B 9 ALA B 12 5 4 HELIX 2 AA2 ASP B 22 HIS B 37 1 16 HELIX 3 AA3 TYR B 60 GLN B 64 5 5 HELIX 4 AA4 ARG B 65 ILE B 69 5 5 HELIX 5 AA5 SER B 71 PHE B 75 5 5 HELIX 6 AA6 GLY B 80 ASP B 84 5 5 HELIX 7 AA7 THR B 85 LEU B 94 1 10 HELIX 8 AA8 PHE A 9 ALA A 12 5 4 HELIX 9 AA9 ASP A 22 HIS A 37 1 16 HELIX 10 AB1 TYR A 60 GLN A 64 5 5 HELIX 11 AB2 ARG A 65 ILE A 69 5 5 HELIX 12 AB3 SER A 71 PHE A 75 5 5 HELIX 13 AB4 GLY A 80 ARG A 83 5 4 HELIX 14 AB5 THR A 85 LEU A 94 1 10 SHEET 1 AA1 6 THR B 14 THR B 17 0 SHEET 2 AA1 6 LEU B 151 VAL B 154 -1 O LEU B 151 N THR B 17 SHEET 3 AA1 6 ARG B 121 THR B 127 -1 N HIS B 123 O TYR B 152 SHEET 4 AA1 6 ALA B 170 THR B 177 -1 O ILE B 171 N VAL B 126 SHEET 5 AA1 6 PRO B 98 LEU B 106 -1 N ARG B 102 O VAL B 174 SHEET 6 AA1 6 THR B 44 ALA B 48 -1 N LEU B 47 O ILE B 103 SHEET 1 AA2 2 GLN B 50 HIS B 51 0 SHEET 2 AA2 2 GLU B 77 VAL B 78 -1 O GLU B 77 N HIS B 51 SHEET 1 AA3 4 TYR B 110 CYS B 111 0 SHEET 2 AA3 4 HIS B 160 ASN B 164 -1 O ASN B 164 N TYR B 110 SHEET 3 AA3 4 ALA B 132 PHE B 136 -1 N VAL B 135 O SER B 161 SHEET 4 AA3 4 LYS B 141 LEU B 143 -1 O LYS B 141 N PHE B 136 SHEET 1 AA4 6 THR A 14 THR A 17 0 SHEET 2 AA4 6 LEU A 151 VAL A 154 -1 O LEU A 151 N THR A 17 SHEET 3 AA4 6 ARG A 121 THR A 127 -1 N HIS A 123 O TYR A 152 SHEET 4 AA4 6 ALA A 170 THR A 177 -1 O ILE A 171 N VAL A 126 SHEET 5 AA4 6 PRO A 98 LEU A 106 -1 N ARG A 102 O VAL A 174 SHEET 6 AA4 6 THR A 44 ALA A 48 -1 N LEU A 47 O ILE A 103 SHEET 1 AA5 2 GLN A 50 HIS A 51 0 SHEET 2 AA5 2 GLU A 77 VAL A 78 -1 O GLU A 77 N HIS A 51 SHEET 1 AA6 4 TYR A 110 CYS A 111 0 SHEET 2 AA6 4 HIS A 160 ASN A 164 -1 O ASN A 164 N TYR A 110 SHEET 3 AA6 4 ALA A 132 PHE A 136 -1 N VAL A 135 O SER A 161 SHEET 4 AA6 4 LYS A 141 LEU A 143 -1 O LYS A 141 N PHE A 136 CRYST1 150.839 39.035 76.591 90.00 119.34 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006630 0.000000 0.003726 0.00000 SCALE2 0.000000 0.025618 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014977 0.00000